|
Fec
I had FEC (strength 75) three years ago for primary cancer. I found it much harder than taxotere. FEC is used alot in Europe and I have noticed that people either seem to find FEC hard or taxotere hard, but usually not both. Like adriamycin, it tends to cause constipation and nausea, but it doesn't cause peripheral neuropathy. It is easier on the heart than adriamycin, although cardiotoxicity is still a concern, which is why it isn't normally mixed with herceptin. A recent Finnish trial for primary cancer suggests, however, that anthracyclines following herceptin-based chemo are much safer than anthracyclines right before herceptin-based chemo.
There was a very successful trial of herceptin, carboplatin, taxotere followed by adriamycin cyclophosphamide announced a little over a year ago, so maybe your mother's oncologist is thinking that two chemo combos are more likely that one to get rid of the cancer for good or at least put it into remission for a long period.
Best of luck,
Christine
|